Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04162756 |
| Title | Study of KTE-X19 for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies (ZUMA-18) |
| Acronym | ZUMA-18 |
| Recruitment | Approved for marketing |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | No |
| Sponsors | Kite, A Gilead Company |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |